Meningococcal Conjugate Vaccine Schedule
Links shared publicly online about this topic
First Meningococcal A Conjugate Vaccine Launched In Burkina Faso
medicalnewstoday.com — “A vaccine that is expected to eradicate the primary cause of meningitis epidemic in Africa is being used across Burkina Faso, starting today, December 6th 2010. If all goes well it will then be us” View full resource at medicalnewstoday.com
Most Recently Shared on December 6, 2010 at 11:07 pm By:
First Meningococcal A Conjugate Vaccine Launched In Burkina Faso A vaccine that is expected to eradicate the primary ca.. http://dld.bz/99Up
Pediatrics News & Articles - MDLinx - Meningococcal-C Conjugated Vaccine on #MDlinx
mdlinx.com — “Pediatrics News & Articles - MDLinx - Meningococcal-C Conjugated Vaccine on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 17, 2010 at 6:35 am By:
Antibody Persistence 12 Months After A Booster Dose of Meningococcal-C Conjugated Vaccine in the Second Year ... http://bit.ly/b37bLR #peds
Meningococcal Conjugate Vaccines Policy Update: Booster Dose Recommendations
pediatrics.aappublications.org — “Meningococcal Conjugate Vaccines Policy Update: Booster Dose Recommendations” View full resource at pediatrics.aappublications.org
Most Recently Shared on November 29, 2011 at 1:23 am By:
It's official. 16 year olds need a booster dose of meningitis vaccine. http://t.co/u0Crjzhx
FDA approves Sanofi Pasteur's meningococcal vaccine
news-medical.net — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.” View full resource at news-medical.net
Most Recently Shared on April 25, 2011 at 11:44 am By:
Meningitis News: FDA approves Sanofi Pasteur's meningococcal vaccine: Sanofi Pasteur, the vaccines division of t... http://bit.ly/eCrvvc
FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur
medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand th” View full resource at medicalnewstoday.com
Most Recently Shared on April 25, 2011 at 4:05 pm By:
FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur http://mnt.to/3TYW
Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010
cdc.gov — “Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010” View full resource at cdc.gov
Most Recently Shared on January 28, 2011 at 2:49 pm By:
Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on… http://goo.gl/fb/yXnsC
AAP updates meningococcal vaccination recommendations
pediatricsupersite.com — “The American Academy of Pediatrics guidelines on the use of quadrivalent meningococcal conjugate vaccines are now in line with those recommended” View full resource at pediatricsupersite.com
Most Recently Shared on December 2, 2011 at 1:43 pm By:
AAP updates meningococcal vaccination recommendations: http://t.co/CZfqs4Se
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age
novartis.com — “FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age” View full resource at novartis.com
Most Recently Shared on January 31, 2011 at 2:19 pm By:
FDA approves Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age - http://ow.ly/3NfGW
Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
novartis.com — “Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease” View full resource at novartis.com
Most Recently Shared on March 18, 2010 at 7:14 am By:
Novartis Menveo is 1st quadrivalent conjugate vaccine approved in EU to help prevent meningococcal disease: http://bit.ly/cbKt7t
This Week in Allergy & Immunology Mar 16 : Atrophic rhinosinusitis, Meningococcal Conjugate Vaccines, Inhaled corticosteroids | Facebook
facebook.com — “This Week in Medicine by Symposier wrote a note titled This Week in Allergy & Immunology Mar 16 : Atrophic rhinosinusitis, Meningococcal Conjugate Vaccines, Inhaled corticosteroids. Read the full text here.” View full resource at facebook.com
Most Recently Shared on March 16, 2011 at 11:30 pm By:
This Week in Allergy & Immunology: Atrophic rhinosinusitis, Meningococcal Conjugate Vaccine, Inhaled corticosteroids http://on.fb.me/gP6mRv
Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants - Apr 22, 2011
sanofipasteurus.mediaroom.com — “Welcome to sanofi pasteur, Sanofi Pasteur US Media Center, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines.” View full resource at sanofipasteurus.mediaroom.com
Most Recently Shared on April 26, 2011 at 8:43 am By:
Sanofi Pasteur Announces FDA Approval of #Menactra Meningococcal Conjugate #Vaccine Indication for Infants. http://ow.ly/4GYoo
Oncology Article | Stem Cell Transplantation Meningococcal Vaccines
mdlinx.com — “Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)” View full resource at mdlinx.com
Most Recently Shared on August 8, 2011 at 10:43 am By:
Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipi... http://bit.ly/qE3uzT #oncology
New vaccine approved to prevent meningococcal disease
pediatricsupersite.com — “FDA officials have approved Novartis' quadrivalent meningococcal conjugate vaccine to prevent invasive meningococcal disease caused by Neisseria” View full resource at pediatricsupersite.com
Most Recently Shared on February 23, 2010 at 3:00 pm By:
New vaccine approved to prevent #meningococcal disease: http://ow.ly/1ak18 #Menveo #Novartis
Meningococcal vaccines show improved efficacy but still problematic
pediatricsupersite.com — “ATLANTA Meningococcal conjugate vaccines have been effective in reducing illness in the United Kingdom for the past decade, but waning im” View full resource at pediatricsupersite.com
Most Recently Shared on July 20, 2010 at 8:30 pm By:
Meningococcal vaccines show improved efficacy but still problematic: http://ow.ly/2e488
Menveo meningococcal vaccine approved for children - ONA
oncologynurseadvisor.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 1, 2011 at 4:17 pm By:
Menveo meningococcal vaccine approved for children http://goo.gl/fb/UUtBV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Dr. Ari Brown
Pediatrician and Co-author of Expecting 411, Baby 411, and Toddler 411 book series
Advertisement

